These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 25869208)

  • 1. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
    Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
    Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.
    Wang Y; Zhang W; Wen L; Yang H; Wen M; Yun Y; Zhao L; Zhu X; Tian L; Luo E; Li Y; Liu W; Wen N
    Oncotarget; 2016 Sep; 7(37):59245-59259. PubMed ID: 27494877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer.
    Francis RE; Myatt SS; Krol J; Hartman J; Peck B; McGovern UB; Wang J; Guest SK; Filipovic A; Gojis O; Palmieri C; Peston D; Shousha S; Yu Q; Sicinski P; Coombes RC; Lam EW
    Int J Oncol; 2009 Jul; 35(1):57-68. PubMed ID: 19513552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.
    Cui J; Xia T; Xie D; Gao Y; Jia Z; Wei D; Wang L; Huang S; Quan M; Xie K
    Oncogene; 2016 Sep; 35(36):4708-18. PubMed ID: 26876216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polydatin inhibits cell proliferation and induces apoptosis in laryngeal cancer and HeLa cells via suppression of the PDGF/AKT signaling pathway.
    Li H; Shi B; Li Y; Yin F
    J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28266802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased sensitivity to the platelet-derived growth factor (PDGF) receptor inhibitor STI571 in chemoresistant glioma cells is associated with enhanced PDGF-BB-mediated signaling and STI571-induced Akt inactivation.
    Servidei T; Riccardi A; Sanguinetti M; Dominici C; Riccardi R
    J Cell Physiol; 2006 Jul; 208(1):220-8. PubMed ID: 16575905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.
    Gong AH; Wei P; Zhang S; Yao J; Yuan Y; Zhou AD; Lang FF; Heimberger AB; Rao G; Huang S
    Cancer Res; 2015 Jun; 75(11):2337-48. PubMed ID: 25832656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
    Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
    Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased erbB3 promotes erbB2/neu-driven mammary tumor proliferation and co-targeting of erbB2/erbB3 receptors exhibits potent inhibitory effects on breast cancer cells.
    Lyu H; Huang J; Edgerton SM; Thor AD; He Z; Liu B
    Int J Clin Exp Pathol; 2015; 8(6):6143-56. PubMed ID: 26261492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.
    Xia L; Mo P; Huang W; Zhang L; Wang Y; Zhu H; Tian D; Liu J; Chen Z; Zhang Y; Chen Z; Hu H; Fan D; Nie Y; Wu K
    Carcinogenesis; 2012 Nov; 33(11):2250-9. PubMed ID: 22831955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer.
    Yang C; Chen H; Yu L; Shan L; Xie L; Hu J; Chen T; Tan Y
    Cancer Gene Ther; 2013 Feb; 20(2):117-24. PubMed ID: 23306612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
    Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C
    Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
    Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
    Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
    Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
    J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
    Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
    Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
    Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
    Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
    Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
    Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
    Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
    Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.